Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9MLH

Xenorhabdus nematophilus XptA2, wild type State 2

これはPDB形式変換不可エントリーです。
9MLH の概要
エントリーDOI10.2210/pdb9mlh/pdb
EMDBエントリー48372
分子名称XptA2 protein (1 entity in total)
機能のキーワードtca, pore forming toxin, toxin
由来する生物種Xenorhabdus nematophila
タンパク質・核酸の鎖数5
化学式量合計1421960.94
構造登録者
Aller, S.G.,Martin, C.L. (登録日: 2024-12-19, 公開日: 2025-01-15, 最終更新日: 2025-03-05)
主引用文献Martin, C.L.,Hill, J.H.,Wright, B.D.,Fernandez, S.R.,Miller, A.L.,Yoon, K.J.,Lapi, S.E.,Aller, S.G.
Evaluating TcAs for Use in Biotechnology Applications.
BioTech (Basel), 14:-, 2025
Cited by
PubMed Abstract: ABC toxin complexes (Tcs) are tripartite complexes that come together to form nano-syringe-like translocation systems. ABC Tcs are often compared with (Bt) toxins, and as such, they have been highly studied as a potential novel pesticide to combat growing insect resistance. Moreover, it is possible to substitute the cytotoxic hypervariable region with alternative peptides, which promise potential use as a novel peptide delivery system. These toxins possess the unique ability to form active chimeric holotoxins across species and display the capability to translocate a variety of payloads across membrane bilayers. Additionally, mutagenesis on the linker region and the receptor binding domains (RBDs) show that mutations do not inherently cause a loss of functionality for translocation. For these reasons, Tcs have emerged as an ideal candidate for targeted protein engineering. However, elucidation of the specific function of each RBD in relation to target receptor recognition currently limits the use of a rational design approach with any ABC Tc. Additionally, there is a distinct lack of targeting and biodistribution data for many Tcs among mammals and mammalian cell lines. Here, we outline two separate strategies for modifying the targeting capabilities of the A subunit (TcA) from , Xn-XptA2. We identify novel structural differences that make Xn-XptA2 different than other characterized TcAs and display the modular capabilities of substituting RBDs from alternative TcAs into the Xn-XptA2 scaffold. Finally, we show the first, to our knowledge, biodistribution data of any TcA in mice.
PubMed: 39982272
DOI: 10.3390/biotech14010005
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.9 Å)
構造検証レポート
Validation report summary of 9mlh
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon